What is CorMedix (CRMD)?
CorMedix is a biopharmaceutical company focused on the development and commercialization of therapeutic products aimed at addressing unmet medical needs in the field of infectious diseases and inflammation. The company specializes in therapies designed to improve patient outcomes by targeting specific biological pathways involved in infection and immune response. CorMedix's research and development efforts include the creation of novel drug candidates that seek to provide alternatives to existing treatments, particularly in areas where antibiotic resistance and inflammatory conditions present significant challenges. The company operates within the broader pharmaceutical industry, collaborating with healthcare professionals and regulatory agencies to advance its product pipeline through clinical trials and regulatory approval processes. CorMedix's mission emphasizes innovation in drug development to enhance the quality of care for patients affected by serious medical conditions. Its activities encompass scientific research, clinical development, and efforts to bring new therapies to market in compliance with industry standards and regulations.
CorMedix Stock Price Today: Live Overview
The price today is shaped by session activity for CorMedix, currently trading at $6.5665. Prices have ranged from $6.4335 to $6.5735, showing a daily change of +1.7151%.
FAQ: CorMedix (CRMD)
What is the current price of CRMD stock?
The last recorded price is $6.5665.
Does CRMD pay dividends?
CorMedix does not pay dividends.
Does CRMD have a formal corporate presence or regional headquarters in the UAE?
CorMedix does not have an official office or subsidiary in the UAE and operates through partners or distributors.
What is CRMD best known for?
CorMedix is most famous for its development of anti-infective therapeutic products.
What assets are typically shown together with CRMD?
Commonly shown alongside CRMD: Daiichi Sankyo Company, Limited, Upexi Inc., Aquestive Therapeutics, Inc.
Latest shares articles



